PL2588091T3 - Sposoby dostarczania medycznej substancji czynnej poprzez podawanie wyrobów do higieny osobistej zawierających filament - Google Patents

Sposoby dostarczania medycznej substancji czynnej poprzez podawanie wyrobów do higieny osobistej zawierających filament

Info

Publication number
PL2588091T3
PL2588091T3 PL11734217T PL11734217T PL2588091T3 PL 2588091 T3 PL2588091 T3 PL 2588091T3 PL 11734217 T PL11734217 T PL 11734217T PL 11734217 T PL11734217 T PL 11734217T PL 2588091 T3 PL2588091 T3 PL 2588091T3
Authority
PL
Poland
Prior art keywords
administration
delivery
methods
products containing
hygiene products
Prior art date
Application number
PL11734217T
Other languages
English (en)
Inventor
Trevor John Darcy
Steven Ray Gilbert
Gregory Charles Gordon
Rajeev Chhabra
William Maxwell Allen Jr.
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of PL2588091T3 publication Critical patent/PL2588091T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D4/00—Spinnerette packs; Cleaning thereof
    • D01D4/02—Spinnerettes
    • D01D4/025—Melt-blowing or solution-blowing dies
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/08—Melt spinning methods
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00—General methods for the manufacture of artificial filaments or the like
    • D01F1/02—Addition of substances to the spinning solution or to the melt
    • D01F1/10—Other agents for modifying properties
    • D—TEXTILES; PAPER
    • D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
    • D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
    • D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
    • D—TEXTILES; PAPER
    • D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H3/00—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length
    • D04H3/08—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the method of strengthening or consolidating
    • D04H3/16—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the method of strengthening or consolidating with bonds between thermoplastic filaments produced in association with filament formation, e.g. immediately following extrusion

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Textile Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL11734217T 2010-07-02 2011-06-30 Sposoby dostarczania medycznej substancji czynnej poprzez podawanie wyrobów do higieny osobistej zawierających filament PL2588091T3 (pl)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US36112910P 2010-07-02 2010-07-02
US36112610P 2010-07-02 2010-07-02
US36115410P 2010-07-02 2010-07-02
US36098210P 2010-07-02 2010-07-02
US36115910P 2010-07-02 2010-07-02
US36113510P 2010-07-02 2010-07-02
US36114610P 2010-07-02 2010-07-02
EP11734217.0A EP2588091B1 (en) 2010-07-02 2011-06-30 Methods of delivering a health care active by administering personal health care articles comprising a filament
PCT/US2011/042641 WO2012003350A1 (en) 2010-07-02 2011-06-30 Methods of delivering a health care active by administering personal health care articles comprising a filament

Publications (1)

Publication Number Publication Date
PL2588091T3 true PL2588091T3 (pl) 2020-08-24

Family

ID=45402453

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11734217T PL2588091T3 (pl) 2010-07-02 2011-06-30 Sposoby dostarczania medycznej substancji czynnej poprzez podawanie wyrobów do higieny osobistej zawierających filament

Country Status (10)

Country Link
US (6) US20120172831A1 (pl)
EP (1) EP2588091B1 (pl)
CN (1) CN102970987A (pl)
AU (1) AU2011272839B2 (pl)
CA (1) CA2803377C (pl)
ES (1) ES2792800T3 (pl)
MX (1) MX2013000201A (pl)
PL (1) PL2588091T3 (pl)
RU (2) RU2613316C1 (pl)
WO (1) WO2012003350A1 (pl)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102971408B (zh) 2010-07-02 2016-03-02 宝洁公司 洗涤剂产品
RU2555042C2 (ru) 2010-07-02 2015-07-10 Дзе Проктер Энд Гэмбл Компани Способ доставки активнодействующего вещества
CN102959150B (zh) 2010-07-02 2016-08-03 宝洁公司 包含可摄取活性剂的长丝、非织造纤维网及其制备方法
US20180163325A1 (en) 2016-12-09 2018-06-14 Robert Wayne Glenn, Jr. Dissolvable fibrous web structure article comprising active agents
RU2543892C2 (ru) 2010-07-02 2015-03-10 Дзе Проктер Энд Гэмбл Компани Способ получения пленок из нетканых полотен
CA2803629C (en) 2010-07-02 2015-04-28 The Procter & Gamble Company Filaments comprising an active agent nonwoven webs and methods for making same
WO2012003350A1 (en) 2010-07-02 2012-01-05 The Procter & Gamble Company Methods of delivering a health care active by administering personal health care articles comprising a filament
PL2680815T3 (pl) * 2011-03-01 2017-02-28 The Procter & Gamble Company Porowate, ulegające rozpadowi stałe podłoże do zastosowań związanych z higieną osobistą
MX2015012309A (es) * 2013-03-15 2015-12-16 Procter & Gamble Articulo para el cuidado personal que comprende fibras disolubles.
CN103224649B (zh) * 2013-05-14 2015-04-22 青岛科凯达橡塑有限公司 一种可降解材料及其制备方法
CN103232618B (zh) * 2013-05-14 2015-04-22 青岛科凯达橡塑有限公司 一种可降解材料及其制备方法
US10849940B2 (en) 2013-06-10 2020-12-01 Brock M. Lundberg Prebiotics of highly refined cellulose
CN103924314A (zh) * 2014-04-25 2014-07-16 邓振平 一种用于治疗艾滋病及并发症的药布
KR101675064B1 (ko) * 2014-11-24 2016-11-10 포항공과대학교 산학협력단 복합추출물을 함유하는 운동수행능력 증강 및 체력증진용 조성물
WO2017058175A1 (en) 2015-09-29 2017-04-06 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
CN105442181B (zh) * 2015-12-30 2018-01-09 闽江学院 一种蜂胶静电纺纳米纤维膜及其生产方法
CN105463702B (zh) * 2015-12-30 2018-03-20 闽江学院 一种含蜂胶的静电复合纺纳米纤维膜及其生产方法
US10773405B2 (en) * 2016-06-30 2020-09-15 The Gillette Company Llc Shaving aid for razor cartridges comprising a nano-filament comprising a core and sheath
EP3573722B1 (en) 2017-01-27 2022-02-23 The Procter & Gamble Company Compositions in the form of dissolvable solid structures comprising effervescent agglomerated particles
MX389431B (es) 2017-02-28 2025-03-20 Kimberly Clark Co Composicion sinergica para el mantenimiento del equilibrio saludable de la microflora.
MX386124B (es) 2017-05-16 2025-03-18 Procter & Gamble Composiciones acondicionadoras para el cuidado del cabello en la forma de estructuras sólidas solubles.
CA3087583C (en) 2018-01-26 2024-01-09 The Procter & Gamble Company Water-soluble unit dose articles comprising perfume
KR20200086739A (ko) 2018-01-26 2020-07-17 더 프록터 앤드 갬블 캄파니 효소를 포함하는 수용성 단위 용량 물품
US11053466B2 (en) 2018-01-26 2021-07-06 The Procter & Gamble Company Water-soluble unit dose articles comprising perfume
JP7127135B2 (ja) 2018-01-26 2022-08-29 ザ プロクター アンド ギャンブル カンパニー 水溶性物品及び関連プロセス
WO2019168829A1 (en) 2018-02-27 2019-09-06 The Procter & Gamble Company A consumer product comprising a flat package containing unit dose articles
AU2019270967B2 (en) 2018-05-14 2021-12-09 The Procter & Gamble Company Oral care compositions comprising metal ions
BR112020022981A2 (pt) * 2018-05-14 2021-02-02 The Procter & Gamble Company dispensador de dentifrício
US11911492B2 (en) 2018-05-14 2024-02-27 The Procter & Gamble Company Oral care compositions comprising metal ions
CN112469289B (zh) * 2018-07-06 2022-12-09 加利福尼亚大学董事会 由水性和/或有机材料制成的物体的并行-增材制造方法
US10982176B2 (en) 2018-07-27 2021-04-20 The Procter & Gamble Company Process of laundering fabrics using a water-soluble unit dose article
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
US12234431B2 (en) 2018-10-03 2025-02-25 The Procter & Gamble Company Water-soluble unit dose articles comprising water-soluble fibrous structures and particles
WO2020159860A1 (en) 2019-01-28 2020-08-06 The Procter & Gamble Company Recycleable, renewable, or biodegradable package
JP7513623B2 (ja) 2019-03-19 2024-07-09 ザ プロクター アンド ギャンブル カンパニー 布地上の悪臭を低減する方法
EP3712237A1 (en) 2019-03-19 2020-09-23 The Procter & Gamble Company Fibrous water-soluble unit dose articles comprising water-soluble fibrous structures
JP7431510B2 (ja) * 2019-04-15 2024-02-15 株式会社リブドゥコーポレーション 吸収性物品
WO2020252498A1 (en) 2019-06-10 2020-12-17 The Procter & Gamble Company Method of generating user feedback information to enhance product use results
AU2020292451A1 (en) 2019-06-13 2021-11-25 The Procter & Gamble Company Kits comprising unit-dose oral care compositions
BR112021023244A2 (pt) 2019-06-28 2022-01-04 Procter & Gamble Artigos fibrosos sólidos dissolvíveis contendo tensoativos aniônicos
CN115867357A (zh) 2020-07-31 2023-03-28 宝洁公司 用于毛发护理的含有球粒的水溶性纤维小袋
JP7605842B2 (ja) 2020-08-19 2024-12-24 ザ プロクター アンド ギャンブル カンパニー 直接添加マイクロカプセルを含有する可撓性多孔質溶解性固体シート物品及びそれを作製するための方法
CN116057220A (zh) * 2020-09-08 2023-05-02 可隆工业株式会社 具有改善的开松质量且无有害残留物的纺粘非织造织物、其制造方法和其制造装置
CN112021483B (zh) * 2020-09-11 2022-07-15 宁波聚焦生物医药科技股份有限公司 一种泡腾凝胶干粉制剂及其制备方法
CN117881380A (zh) 2021-08-30 2024-04-12 宝洁公司 包含第一聚合结构剂和第二聚合结构剂的可溶性固体结构
US11464384B1 (en) 2022-03-31 2022-10-11 Techtronic Cordless Gp Water soluable package for a floor cleaner
CN114575036B (zh) * 2022-04-06 2023-07-21 江苏科溪蔓生物科技有限公司 一种松针基长效抑菌、全降解熔喷布及其制备方法

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723134A (en) 1968-05-17 1973-03-27 Gen Mills Inc Process for making candy floss
US3849241A (en) * 1968-12-23 1974-11-19 Exxon Research Engineering Co Non-woven mats by melt blowing
IT1008202B (it) 1974-07-31 1976-11-10 Lostia Onofrio Fibre inglobanti anticorpi antige ni antisieri procedimento per la loro preparazione e loro impieghi
US4349531A (en) 1975-12-15 1982-09-14 Hoffmann-La Roche Inc. Novel dosage form
US4180558A (en) 1978-08-21 1979-12-25 Hoffmann-La Roche Inc. Unit dosage forms
US4855326A (en) 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
US5034421A (en) 1988-12-13 1991-07-23 Fuisz Pharmaceutical Ltd. Moderated spun fibrous system and method of manufacture
JPH0340879A (ja) 1989-07-07 1991-02-21 Kuraray Co Ltd 薬効性繊維及びその製造方法
JPH03101618A (ja) 1989-09-13 1991-04-26 Kuraray Co Ltd 薬効性繊維及びその製造法
WO1992006603A1 (en) 1990-10-10 1992-04-30 Fuisz Technologies Ltd. Taste masked medicated floss
ES2111065T5 (es) 1991-04-16 2005-06-16 Nippon Shinyaku Company, Limited Procedimiento para producir una dispersion solida.
AU3328193A (en) 1991-12-17 1993-07-19 Fuisz Technologies Ltd. Ulcer prevention and treatment composition and method
US5518730A (en) 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
US5520924A (en) 1993-07-09 1996-05-28 Mizu Systems Corporation Methods and articles for administering drug to the oral cavity
GB9414305D0 (en) * 1994-07-15 1994-09-07 C V Lab Ltd Alginate fibre, process for the preparation thereof and use
US5705183A (en) 1994-11-16 1998-01-06 Phillips Company Cotton candy coated medication and a method for making and administering the same
US5681724A (en) 1995-11-16 1997-10-28 Heska Corporation Parasitic helminth macrophage inhibitory factor nucleic acid molecules and uses thereof
US6165217A (en) * 1997-10-02 2000-12-26 Gore Enterprise Holdings, Inc. Self-cohering, continuous filament non-woven webs
CA2246031C (en) * 1998-08-28 2003-08-05 Norman Dust Boat
WO2000013680A2 (en) 1998-09-09 2000-03-16 Quadrant Holdings Cambridge Limited Filamentous amorphous carbohydrate compositions and therapeutic delivery vehicles comprising them
US6596298B2 (en) 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
DE19856668A1 (de) * 1998-12-09 2000-06-15 Aesculap Ag & Co Kg Wirkstoffmatrix in Form eines biologisch resorbierbaren porösen Vlieses, Verfahren zu ihrer Herstellung und Verwendung
ES2199168T3 (es) * 1999-07-02 2004-02-16 THE PROCTER & GAMBLE COMPANY Sistema de administracion para composiciones para el cuidado bucal que comprenden resinas de organosiloxano usando una barra de soporte extraible.
EP1090928B1 (en) 1999-09-30 2004-05-26 Chienna B.V. Polymers loaded with bioactive agents
AU6132700A (en) 1999-09-30 2001-04-05 Chienna B.V. Polymers loaded with bioactive agents
EP1120109A3 (en) 2000-01-24 2002-07-10 Pfizer Products Inc. Rapidly disintegrating and fast dissolving solid dosage form
MXPA02007298A (es) * 2000-01-28 2002-12-09 Smithkline Beecham Corp Composiciones farmaceuticas electrostaticamente hiladas.
WO2002060921A2 (en) 2000-11-09 2002-08-08 Board Of Trustees Of The University Of Illinois Enhancement of immune response to vaccine by interferon alpha
EP1372604A2 (en) 2001-03-22 2004-01-02 Battelle Memorial Institute Manufacturing dissolvable dosage forms
US20060189526A1 (en) 2002-04-24 2006-08-24 Podolsky Daniel K Compositions containing an intestinal trefoil peptide and a mucoadhesive
US7491407B2 (en) 2001-10-31 2009-02-17 North Carolina State University Fiber-based nano drug delivery systems (NDDS)
DE10207394B4 (de) * 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Geschmacksmaskierte oblatenförmige Arzneizubereitung
US20030017208A1 (en) 2002-07-19 2003-01-23 Francis Ignatious Electrospun pharmaceutical compositions
US20060083784A1 (en) 2002-08-07 2006-04-20 Smithkline Beecham Corporation Amorphous pharmaceutical compositions
US7662257B2 (en) * 2005-04-21 2010-02-16 Georgia-Pacific Consumer Products Llc Multi-ply paper towel with absorbent core
EP1639159B2 (en) * 2003-06-30 2018-07-18 The Procter & Gamble Company Coated nanofiber webs
US20050136112A1 (en) 2003-12-19 2005-06-23 Pediamed Pharmaceuticals, Inc. Oral medicament delivery system
US7856989B2 (en) 2004-12-30 2010-12-28 Philip Morris Usa Inc. Electrostatically produced fast dissolving fibers
WO2006106514A2 (en) 2005-04-06 2006-10-12 Nicast Ltd. Electrospun dosage form and method of producing the same
WO2007089259A1 (en) 2006-02-02 2007-08-09 The Johns Hopkins University Therapeutic electrospun fiber compositions
US20080220054A1 (en) 2006-10-13 2008-09-11 Shastri V Prasad Modulation of drug release rate from electrospun fibers
CA2667213C (en) 2006-10-23 2015-12-29 Eth Zurich Fibrous pharmaceutical and implant materials
US20100166854A1 (en) 2006-10-30 2010-07-01 Rutgers, The State University Of New Jersey Electrospun matrices for delivery of hydrophilic and lipophilic compounds
DE102007011606A1 (de) 2007-03-02 2008-09-04 Carl Freudenberg Kg Faser-Wirrgelege
US20100018641A1 (en) * 2007-06-08 2010-01-28 Kimberly-Clark Worldwide, Inc. Methods of Applying Skin Wellness Agents to a Nonwoven Web Through Electrospinning Nanofibers
KR100937625B1 (ko) 2007-08-10 2010-01-20 주식회사 제닉 가용성 웹 공극필름 및 이의 제조방법
US8974814B2 (en) 2007-11-12 2015-03-10 California Institute Of Technology Layered drug delivery polymer monofilament fibers
US8906815B2 (en) 2007-12-28 2014-12-09 3M Innovative Properties Company Composite nonwoven fibrous webs and methods of making and using the same
US20110129510A1 (en) 2008-08-08 2011-06-02 Basf Se Fibrous surface structure containing active ingredients with controlled release of active ingredients, use thereof and method for the production thereof
BR112012002152A2 (pt) 2009-07-30 2016-06-07 Procter & Gamble artigo de tratamento bucal
US7900713B2 (en) 2009-08-07 2011-03-08 Top Gearbox Industry Co., Ltd. Main shaft locking mechanism
WO2012003350A1 (en) 2010-07-02 2012-01-05 The Procter & Gamble Company Methods of delivering a health care active by administering personal health care articles comprising a filament

Also Published As

Publication number Publication date
US10517836B2 (en) 2019-12-31
US20200060984A1 (en) 2020-02-27
US20120172831A1 (en) 2012-07-05
RU2012158241A (ru) 2014-08-10
US20180289628A1 (en) 2018-10-11
US10912738B2 (en) 2021-02-09
EP2588091B1 (en) 2020-04-15
CN102970987A (zh) 2013-03-13
AU2011272839B2 (en) 2015-04-02
CA2803377A1 (en) 2012-01-05
AU2011272839A1 (en) 2013-01-17
ES2792800T3 (es) 2020-11-12
EP2588091A1 (en) 2013-05-08
US9801830B2 (en) 2017-10-31
RU2613316C1 (ru) 2017-03-15
US10449163B2 (en) 2019-10-22
CA2803377C (en) 2018-03-20
US11964059B2 (en) 2024-04-23
US20130253017A1 (en) 2013-09-26
US20210154150A1 (en) 2021-05-27
MX2013000201A (es) 2013-08-21
US20180015048A1 (en) 2018-01-18
WO2012003350A1 (en) 2012-01-05
RU2535040C2 (ru) 2014-12-10

Similar Documents

Publication Publication Date Title
PL2588091T3 (pl) Sposoby dostarczania medycznej substancji czynnej poprzez podawanie wyrobów do higieny osobistej zawierających filament
HUS1900031I1 (hu) Hatóanyagok légúti beadása
IL276643A (en) Methods to increase the transfer of drugs and the effectiveness of therapeutic agents
IL287381A (en) Pharmaceutical preparations of human rpe cells and uses thereof
IL272501A (en) Oral administration forms of bendamustine and their medical use
EP2768571A4 (en) MEDICAL ACTIVE COMPOSITION DEVICE
EP2782631A4 (en) IMPLANTABLE APPARATUS FOR USE IN THE ADMINISTRATION OF A SOLID-LIQUID MEDICAMENT, ASSOCIATED FORMULATIONS AND METHODS OF USE
EP2593039A4 (en) MEDICAL ACTIVE COMPOSITION DEVICE
EP2771043A4 (en) ACTIVE RELEASE PROCEDURE
PL2464342T3 (pl) Formulacje farmaceutyczne do zapobiegania niewłaściwemu użyciu leków medycznych
TW201129382A (en) Antibody formulation and therapeutic regimens
SMT201500026B (it) Contatori di dosi per inalatori inalatori e steli degli stessi
PL2998289T3 (pl) Związki do nakierowywania dostarczania leku i podwyższające aktywność sirna
IL222132B (en) Use of cannabidivarin for the preparation of medicaments for treating epilepsy or epileptic seizures
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
ZA201400616B (en) Methods and devices for drug delivery to ocular tissue using microneedle
EA201391119A1 (ru) Системы доставки наночастиц, их получение и применение
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
EP2790736A4 (en) IN VIVO ADMINISTRATION OF OLIGONUCLEOTIDES
EP2575950A4 (en) ADMINISTRATION OF ORAL CARE PRODUCTS
EP2543366A4 (en) FILM PREPARATION WITH MEDICAMENT WITH INDEPENDENT TASTE
BRPI1006040A2 (pt) uso de composições farmacêuticas, tipo de curativo médico, e, tipo de caixa de medicamento
IL232157A0 (en) Implantable drug delivery preparations and treatment methods thereof
ES2446643R1 (es) Composiciones farmacéuticas combinadas y su uso para preparar un medicamento destinado al tratamiento del vértigo, la cinetosis y la distonía vegetativa-vascular
EP2452701A4 (en) MEDICAL INSTRUMENT FOR ADMINISTERING A MEDICINE